John Anderson, MD, talks about the efforts of the American Diabetes Association, and how they are using the successful experiences they have gained through landmark studies such as the Diabetes Prevention Program (DPP), applying this knowledge to new initiatives such as outreach into the community through the YMCA and other …
Read More »John Anderson, MD, Q4: At what A1c should we start to treat diabetes?
John Anderson, MD, talks about how clinicians should look at more than just a specific A1c number when beginning treatment for diabetes explaining that the measure is really only a way to project future risk. Factors such as family history, ethnic background and other characteristics may be more relevant. But …
Read More »John Anderson, MD, Q2: Thoughts on SGLT-2 Inhibitors
John Anderson, MD, talks about the new SGLT-2 inhibitors, what he has heard so far on their efficacy, and some of the concerns that have been raised about this new class of drugs…. See more SGLT-2 Resources More videos with John Anderson, MD: John Anderson, MD, ADA Board of Directors, …
Read More »Sean Duffy, Co-founder & CEO, Omada Health, Introduction
Sean Duffy, Co-founder & CEO, Omada Health, tells us a little about himself, how he came to be involved in starting up PreventNow.com, where the company is headed, and how they fill a niche in the market by finding ways to use their technological know-how to help solve healthcare problems. …
Read More »Sean Duffy, Omada Health, Q1: Why Focus on Prediabetes?
Sean Duffy, Omada Health, talks about why PreventNow is focused on prediabetes rather than diabetes. He explains that it was interesting to his team because of a broad clinical consensus that there is a fantastic opportunity to intervene and make a huge difference in someone’s life. A national framework already exists …
Read More »Sean Duffy, Omada Health, Q2: How Do You Raise Prediabetes Awareness?
Sean Duffy, Omada Health, explains how Omada is finding its target audience, the large numbers of people in the U.S. with prediabetes who don’t even know they have it. He points out that, although many don’t know, through more biometric screenings and awareness raising programs, people are becoming aware of …
Read More »Sean Duffy, Omada Health: What Is the Silver Bullet for Prediabetes?
Sean Duffy, Omada Health, explains some of the guiding principles behind PreventNow and why it works so well. One key insight involved studying why the programs in which people met face-to-face were so successful. Using this knowledge and melding it with their high-tech know-how, Omada was able to create a …
Read More »Sean Duffy, Omada Health, Q4: Is the PreventNow Program Available Yet?
Sean Duffy, Omada Health, gives us some of the details on how patients can sign up for PreventNow.com if they want. Individuals can sign up but Omada is also working with larger organizations to allow for less expensive sign-ups. Managed Care sign-ups may also have a different incentive structure but …
Read More »Sean Duffy, Omada Health, Q5: How Do You Measure Success?
Sean Duffy, Omada Health, explains that the metrics for determining the success of PreventNow were largely based on looking at what previous programs had achieved with diabetes patients. Engagement and weight loss were two of the factors that were tracked. Participants in the program had about 5-7% weight loss. More …
Read More »Sean Duffy, Omada Health, Q6: How Good Have PreventNow’s Results Been?
Sean Duffy, Omada Health, talks about the launch of PreventNow which began in January 2013. Previous to the public launch, there was a 220 person beta test. The prediabetic participants were notably enthusiastic about the program with about 74% people completing and an average 6% weight loss. Many of those who …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.